[Biosynthesis-based production improvement and structure modification of erythromycin A]
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|December 18, 2015
Summary
This review covers genetic engineering of erythromycin A (antibiotic) production strains. We explore methods for improving yields and modifying the antibiotic
Area of Science:
- Microbiology
- Biochemistry
- Genetic Engineering
Background:
- Erythromycin A is a vital broad-spectrum macrolide antibiotic.
- Its biosynthesis relies on polyketide synthases and post-assembly modifications.
- Understanding biosynthesis enables strain manipulation for enhanced production.
Purpose of the Study:
- To review advancements in constructing high-producing erythromycin A strains.
- To summarize progress in erythromycin A chemical structure derivation.
- To offer insights for future research and development.
Main Methods:
- Literature review of genetic manipulation techniques.
- Analysis of studies on polyketide synthase pathways.
- Examination of methods for chemical modification of erythromycin A.
Main Results:
- Genetic engineering offers effective strategies for erythromycin A production improvement.
- Diverse modification pathways allow for structural derivation of erythromycin A.
- Progress in strain construction and structure modification is significant.
Conclusions:
- Genetic manipulation of erythromycin A-producing strains is a viable approach for optimization.
- Further research can lead to novel erythromycin A derivatives with improved properties.
- This review provides a foundation for future advancements in antibiotic development.
Related Concept Videos
01:27Production of Antibiotics
58
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
58
01:30Production of Pharmaceuticals
51
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
51
01:22Bioreactor Controls-III
51
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
51
01:24Biosynthesis in Bacteria
955
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
955
01:25Inhibitors of Bacterial Protein Synthesis
31
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
31
01:29Amino Acid Biosynthetic Pathways
1.6K
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
1.6K